Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
ALBO

Overview Financials Analysis Smart Money

Albireo Pharma, Inc.

ALBO · NASDAQ

Analyze with AI

Filings2

Total reported value$13.2K

Manager	Shares	Value	Change
Sargent Bickham Lagudis LLC	300	$13.2K	0.0%
APOGEM CAPITAL LLC	0	$0.0	+100.0%

SymbolALBO

Market Cap$915.9M

IPO Date2007-05-11

CEORonald H. W. Cooper

Employees130

SectorHealthcare

IndustryBiotechnology

CountryUS

ExchangeNASDAQ Capital Market

Luminar Technologies, Inc.

LAZR

$0.6044

+174.73%

Crown ElectroKinetics Corp.

CRKN

$0.11

+115.69%

NovaBay Pharmaceuticals, Inc.

NBY

$5.30

+79.66%

Mint Incorporation Limited

MIMI

$0.4795

+75.45%

Autozi Internet Technology (Global) Ltd.

AZI

$2.50

+64.47%

Peers

Poseida Therapeutics, Inc.

PSTX · NASDAQ

$9.50

+0.00%

Verve Therapeutics, Inc.

VERV · NASDAQ

$11.13

+0.27%

Gracell Biotechnologies Inc.

GRCL · NASDAQ

$10.25

+0.05%

Harpoon Therapeutics, Inc.

HARP · NASDAQ

$23.01

+0.09%

Icosavax, Inc.

ICVX · NASDAQ

$15.31

-0.91%

Chimerix, Inc.

CMRX · NASDAQ

$8.54

+0.00%

Avid Bioservices, Inc.

CDMO · NASDAQ

$12.49

+0.00%

VectivBio Holding AG

VECT · NASDAQ

$16.87

+0.12%

Crescent Biopharma, Inc.

CBIO · NASDAQ

$11.85

-3.03%

Intercept Pharmaceuticals, Inc.

ICPT · NASDAQ

$19.00

+0.21%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.